Whoop Unveils New Women’s Health Blood Test
▼ Summary
– Whoop is launching a new women’s health blood panel with 11 biomarkers to provide insights into cycle regulation, hormones, and nutrient levels.
– The company is also adding a Hormonal Symptom Insights feature to its app, which models and predicts menstrual cycles based on user data.
– These new features are part of a broader industry trend where fitness wearable companies are expanding services to address women’s health.
– Whoop reported that women are its fastest-growing user segment, with a 150% increase in female users over the past year.
– The new blood test will be available for purchase starting next month, following a high initial demand for its blood testing service.
Fitness technology company Whoop is expanding its health monitoring platform with a dedicated focus on women. The brand is introducing a specialized blood test panel through its Whoop Labs service, designed to provide deeper insights into female physiology. Alongside this diagnostic tool, the app is gaining a new feature that models and predicts hormonal changes throughout the menstrual cycle, aiming to offer a more personalized health overview.
The new blood panel evaluates eleven key biomarkers, including Anti-Müllerian Hormone (AMH), Progesterone, Prolactin, and various thyroid and nutrient indicators like Vitamin B12 and Magnesium. Whoop suggests that analyzing these markers can illuminate aspects of cycle regulation, perimenopause, thyroid function, and bone metabolic resilience. This data becomes more powerful when combined with the wearable’s continuous tracking of activity, sleep, and recovery metrics. The test will be available for purchase starting next month.
Complementing the lab service, the app’s Hormonal Symptom Insights and Predictions feature builds a model based on a user’s historical cycle data. This model forecasts potential windows for the next period, provides analysis on cycle length and irregularities, and details individual symptom patterns. The company states it can integrate these insights with blood test results, categorizing biomarker findings as ‘optimal,’ ‘sufficient,’ or ‘out of range’ to give context to the numbers.
This move aligns with a broader industry trend where wearable tech companies are increasingly developing features for women’s health, a segment that has historically been underserved. Whoop reports its female user base is its fastest-growing demographic, having increased by 150% over the past year. The company also notes that women engage with its AI coaching feature 30% more than other users. This strategic focus follows similar initiatives from competitors, such as Oura’s recent launch of a women’s health AI model and a dedicated data insights chatbot.
To support these new offerings, Whoop has published a white paper detailing the research and modeling behind its menstrual cycle features. The company initially launched its blood testing service in September 2025 to significant interest, with a waitlist exceeding 350,000 people.
(Source: TechCrunch)